Technical analysis of Apollomics, Inc. (APLM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements.
Price Performance
| 1 month | -7.57% |
| 3 months | +26.34% |
| Year-to-date | +18.24% |
| 1 year | +19.97% |
| 3 years | -94.35% |
52-Week Range
| 52-week High | $42.12 |
| 52-week Low | $9.00 |
| Avg Volume (90d) | 20K |
Technical Indicators
| SMA 50 | $21.19 |
| SMA 200 | $18.26 |
| Beta | 1.83 |
| 30-day Volatility (annualised) | 110.0% |
| Price vs SMA 50 | +4.3% |
| Price vs SMA 200 | +21.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $13.97 | |
| 2025-11 | $15.05 | +7.7% |
| 2025-12 | $18.70 | +24.3% |
| 2026-01 | $18.30 | -2.1% |
| 2026-02 | $20.21 | +10.4% |
| 2026-03 | $15.85 | -21.6% |
| 2026-04 | $13.00 | -18.0% |
| 2026-05 | $14.15 | +8.8% |
| 2026-06 | $20.96 | +48.1% |
| 2026-07 | $17.25 | -17.7% |
| 2026-08 | $27.09 | +57.0% |
| 2026-09 | $22.11 | -18.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $22.11 |
| Market Cap | $49M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -2.92 |
| EV / EBITDA | -6.10 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.20 |
| Current Ratio | 0.96 |